Fund profile / Denmark

Novo Holdings (Life Sciences Fund)

Geography: Denmark
Stage: Series A
Fund size: $1800M
Focus: Deep Tech and SaaS
Signals: Published

N°01 / About

About Novo Holdings (Life Sciences Fund)

Novo Holdings (Life Sciences Fund) is a venture capital firm based in Denmark, focusing on Series A stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionDenmark

Funding StageSeries A

Industry Focus

Deep Tech

SaaS

Investor Signals Profile

active

Sweet Spot

Life science/bio-sustainability founder, all stages, global reach

life science

bio-sustainability

healthcare

impact investing

responsible capital

Bullish Signals

DKK 694bn AUM, record 2025 returnsexternal

9.2% CER return despite market volatilityexternal

Offices in 7 global citiesexternal

$125M Series A co-lead, April 2026external

Active deals Q1–Q2 2026external

$50M growth deal, Route 92 Medicalwebsite

India healthcare expansion, Jan 2026website

8.6% 10-yr avg annual portfolio returnwebsite

KabaFusion exit closed Jan 2026website

DKK 20bn record total income 2025website

Myricx Bio acquired by Novartis, June 2026website

Hemab Therapeutics Nasdaq IPO success, June 2026website

LimmaTech acquired by Lilly, May 2026website

HST Pathways strategic growth investment, May 2026website

Values-driven, high performance culture globallywebsite

Aspires catalysts for change, alleviate human/planetary healthwebsite

ForYou Medical advanced wound care investment, Oct 2026website

7 offices: Copenhagen, London, SF, Boston, Singapore, Shanghai, Mumbaiwebsite

Strives high performance with respect, responsibilitywebsite

Leading responsible investor aspiration, societal impact focuswebsite

Contrarian Signals

Primarily foundation-backed, not pure VCexternal

Life science focus limits scopeexternal

Novo Group concentration riskexternal

2.3% portfolio return in 2025 vs 9.2% CERwebsite

Founder Do's

Focus on healthcare or bio-sustainability

Show long-term return potential

Demonstrate societal/planetary impact

Be open to all dev stages

Align with responsible investment values

Founder Don'ts

Pitch non-life-science, non-impact plays

Expect short-term exit pressure

Ignore ESG/sustainability angle

33 signals on Novo Holdings (Life Sciences Fund)

20 bullish · 4 contrarian · 5 pitch do's · 3 don'ts · 1 GP profile, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size$1800M

Saves0

Website

People

Key People

Kasim Kutay, Christoffer Søderberg

Kasim KutayCEO

N°04 / See also

Related Funds

Seed Capital V

Fund size$500M

Location: Denmark
Stage: Seed
Focus: Saas
Manager: Ulla Brockenhuus Schack, Christian Broendum

Seed

Saas

Seed Capital Fund V

Fund size€130M

Location: Denmark
Stage: Series A
Focus

Series A

Climentum Capital Fund II

Fund size€100M

Location: Denmark
Stage: Seed
Focus: Energy Tech, Deep Tech, Climate Sustainability
Manager: Morten Halborg, Dörte Hirschberg, Stefan Mård, Jennifer Dungs

Seed

Energy Tech

Deep Tech

Climate Sustainability